Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services worldwide. It operates through three primary segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that support the development and manufacture of therapeutics, including cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill finish, single-use hardware, lab filtration, separation, purification tools, protein purification instruments, reagents, membranes, and healthcare filtration solutions. The Life Sciences segment offers mass spectrometers, bioanalytical measurement systems, flow cytometry, genomics, lab automation, centrifugation, liquid handling instruments, antibodies, particle counting and characterization, genome sample preparation, microscopes, protein consumables, filtration products, and genomic medicines such as custom nucleic acid products, plasmid DNA, RNA, and proteins under brands like ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX. The Diagnostics segment delivers clinical instruments, consumables, software, and services for clinical chemistry, immunoassay, hematology, and microbiology in hospitals, physicians’ offices, reference laboratories, and critical care settings, including a partnership with AstraZeneca to develop diagnostic tools and tests. Founded in 1984 and headquartered in Washington, D.C., Danaher Corporation plays a vital role in advancing life sciences, diagnostics, and biotechnology innovation.